Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus.
托格列净和阿格列汀单独或联合用药对 2 型糖尿病患者葡萄糖代谢和动脉粥样硬化相关标志物的影响
期刊:Clinical Pharmacology-Advances and Applications
影响因子:2.5
doi:10.2147/CPAA.S409786
Nomura Shosaku, Shouzu Akira, Taniura Takehito, Okuda Yoshinori, Omoto Seitaro, Suzuki Masahiko, Ito Tomoki, Toyoda Nagaoki
